January 2026: China to End VAT Export Rebates on E-Cigarette Products from April 2026
China will cancel value-added tax (VAT) export rebates on e-cigarette products containing nicotine starting April 1, 2026, marking another tightening of fiscal and regulatory conditions for the country’s large vaping export sector. The decision, jointly issued by the Ministry of Finance and the State Taxation Administration, adds nicotine e-cigarettes to the list of products no longer eligible for VAT export rebates. The move is part of a broader adjustment to China’s export tax rebate system, signaling a policy shift away from supporting certain export-oriented industries through tax refunds.
Under the new rules, most finished e-cigarette products with nicotine will lose eligibility for VAT rebates, while the treatment of related components such as battery packs will depend on how they are declared under customs codes. If batteries are exported separately and fall under battery-specific classifications, they may still be subject to transitional rebate arrangements before those are phased out entirely in 2027. This creates additional complexity for exporters in terms of product structuring and customs compliance. For manufacturers, the cancellation of VAT export rebates is expected to raise effective export costs and put pressure on margins – further weakening the financial resilience of the Chinese e-cigarette industry.
January 2026: China Moves Oral Nicotine Products into the State Tobacco Monopoly Regulatory Framework
China’s State Tobacco Monopoly Administration (STMA) formally classified nicotine pouches and other smokeless nicotine products under the country’s tobacco monopoly regulatory regime, ending a long-standing legal grey area for these products. An STMA announcement, dated January 6, 2026 and effective immediately, defines “smokeless tobacco products” – including nicotine pouches, oral strips, patches, snus, chewing tobacco, and snuff – as subject to the same rules that govern traditional cigarettes and cut tobacco. This represents the first clear regulatory status for oral nicotine products in China, which were previously not explicitly addressed under existing laws.
Under the new classification, oral nicotine products will be governed under China’s traditional tobacco control system rather than the regulatory framework developed for e-cigarettes. In practice, this subjects production, distribution, and branding to the highly centralized state tobacco monopoly, which tightly controls licensing, capacity and market access. The regulatory move also places smokeless tobacco products within the limited industrial policy category, meaning investments, factory construction, and capacity expansion will require approval. As a result, private manufacturers and independent brands may find it increasingly difficult to operate in China’s domestic market unless they are integrated into the state tobacco system.
The policy shift comes amid a broader tightening of oversight across the tobacco and nicotine product landscape. In late 2025, China’s State Council called for comprehensive action against illicit tobacco activities, and subsequent regulatory efforts have increasingly clarified the supervision of novel nicotine products, including draft rules for e-cigarette enterprises and stricter controls on e-cigarette production capacity. These developments signal China’s intention to institutionalize governance and reduce regulatory ambiguity across all nicotine product categories.
The move also aligns with other enforcement actions targeting nicotine products, such as recent large seizures by Chinese customs of imported oral nicotine pouches – including alleged trademark-infringing ZYN products – under tobacco monopoly oversight. Authorities have indicated that exports of oral nicotine products require specific transport permits and export licenses, further reinforcing the application of tobacco regulation to these goods.
November 2021: China Brings E-Cigarettes Under State Tobacco Monopoly
China amended its tobacco monopoly law to formally include e-cigarettes, marking a pivotal shift in the regulatory treatment of vaping products. The move brought the rapidly expanding e-cigarette sector under the authority of the state-controlled tobacco regulatory framework, aligning it with traditional tobacco products.
This amendment effectively ended the industry’s previous regulatory ambiguity, granting the State Tobacco Monopoly Administration oversight of production, distribution, and sales. It also signaled Beijing’s intent to exert tighter control over a fast-growing segment within the world’s largest tobacco market, where both consumption and manufacturing of vaping products are significant.
Beyond clarifying legal status, the reform laid the groundwork for subsequent measures – including licensing requirements, product standards, and taxation – integrating e-cigarettes into China’s broader tobacco control and industrial policy framework. The policy reflects a dual objective: to regulate public health risks associated with vaping while consolidating state control over an emerging nicotine category within China’s existing tobacco monopoly system.
